Skip to main content

Oaktree Acquisition Corp. III Life Sciences

For the period ended Jun 30, 2025. Filed Aug 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 12, 2025

OACC$10.70-0.2%Stored close · as of Nov 5, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2025-03-31; filed 2025-05-14.

0001193125-25-119885

Item 1A. Risk Factors

Current report: 10-Q

Period ended 2025-06-30; filed 2025-08-12.

0001193125-25-178570

Item 1A. Risk Factors

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 5 previous paragraphs and 5 current paragraphs.

1 unchanged; 2 reworded; 2 added; 2 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (2)
Removed paragraphs (2)
Reworded paragraphs (2)

Previous wording

Factors that could cause our actual results to differ materially from those in this Report include the risk factors described in our Annual Report on Form

Current wording

Factors that could cause our actual results to differ materially from those in this Report include the risk factors described in our Annual Report on

Previous wording

for the year ended December 31, 2024 filed with the SEC on March 27, 2025. As of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form

Current wording

for the year ended December 31, 2024 filed with the SEC on March 27, 2025. As of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on